The Future Of BP Control: FDA Approves Pill That Can Lower Cholesterol Better Th.

Merck's Lipfendra has become the first FDA-approved oral PCSK9 inhibitor, offering adults with high LDL a once-daily alternative to injectable therapies for lowering cardiovascular risk.